Insider Selling: Tempus AI, Inc. (NASDAQ:TEM) Major Shareholder Sells 170,720 Shares of Stock

Tempus AI, Inc. (NASDAQ:TEM) major shareholder Bradley A. Keywell sold 170,720 shares of Tempus AI stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $35.45, for a total transaction of $6,052,024.00. Following the completion of the transaction, the insider now directly owns 15,993,729 shares in the company, valued at $566,977,693.05. The trade was a 1.06 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Tempus AI Price Performance

Shares of TEM traded up $0.40 during mid-day trading on Friday, hitting $35.15. The company’s stock had a trading volume of 2,434,717 shares, compared to its average volume of 3,919,255. The stock’s 50-day moving average is $46.80 and its two-hundred day moving average is $47.09. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. Tempus AI, Inc. has a one year low of $22.89 and a one year high of $79.49.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the stock. Needham & Company LLC reiterated a “buy” rating and issued a $56.00 price target on shares of Tempus AI in a report on Tuesday. Loop Capital lowered their target price on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research note on Tuesday. Wolfe Research began coverage on shares of Tempus AI in a research report on Friday, December 13th. They set an “outperform” rating and a $60.00 price target on the stock. Bank of America increased their price target on Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a research report on Friday, December 13th. Finally, Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and raised their target price for the company from $45.00 to $65.00 in a research note on Monday, November 11th. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $56.36.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. First Horizon Advisors Inc. bought a new stake in shares of Tempus AI in the 3rd quarter worth approximately $30,000. FNY Investment Advisers LLC acquired a new stake in shares of Tempus AI during the 4th quarter valued at about $67,000. Sandia Investment Management LP bought a new position in shares of Tempus AI during the second quarter valued at $136,000. Vestor Capital LLC bought a new stake in Tempus AI during the 3rd quarter worth approximately $153,000. Finally, Stifel Financial Corp acquired a new position in shares of Tempus AI during the third quarter worth approximately $218,000. Institutional investors own 24.22% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.